Access Curated Private Market Opportunities
Award-winning Platform Empowering Innovation, Capital and Ambition, Globally
-
0
+
Investors & Deal Makers
-
0
Unicorns
-
0
Year track record
POWERED BY CapitalHQTM
Utilise our cutting-edge AI-powered platform to access curated Private Opportunities. Discover Startups, Scaleups, Fund Managers, Private Equity, Property, Small Cap Listed and Secondary Market Opportunities
Join an exclusive ecosystem of High-Net-Worth, Professional, Institutional, VC and Family Office Investors. Receive personalised deal flow, streamlined information access and access to investment insights from leading global Fund Managers and Investors
Access Exclusive Private Opportunities
Get access to curated growth companies, property opportunities, alternative funds, investment insights and exclusive investor networking events
- Free Account Set up
- No transaction fees
- Direct Access to CEOs and Managers
- Curated Global Deal Flow
QBiotics Group
The Insides Company
NanoFynd Pty Ltd
Elemental IV
SoHi Partners
A Personalised Pipeline of Opportunities
Let our AI/ML provide you with personalised, exclusive and consistent deal flow
QBiotics Group
The Insides Company
NanoFynd Pty Ltd
Elemental IV
SoHi Partners
- Overview
- Market Opportunity
- Competitive Advantage
- Highlights and Milestones
- Investment Offering
Streamlined Investor Experience
Access the information you want and need, in a structured, clear format.
Trusted by hundreds of companies worldwide
Our international clientele includes leading emerging growth companies, funds, governments, universities, incubators, accelerators and advisory firms.
Premier Investor Events and Conferences
See exclusive pitches, product demos, and talk with founders
In person or online
Yield & Growth – Investment Conference – SYDNEY 2026
Yield & Growth – Investment Conference – SINGAPORE 2026
As seen in
News and announcements
Our Clients’ Major Breakthrough and Milestones
Everything is now competing for the same dollar
Key takeaways As recently as 2022, Germany and Japan could borrow for 30 years at close to zero. That world is gone, and AI is now bidding for what is left. Over the past fortnight, I listened to founders, operators and allocators describe where their industries are heading. They covered four very different frontiers. Each […]
Australia has not held 90 days of fuel since 2012. The fix may start at a sewage plant.
A decommissioned council treatment site in Bundaberg is being built into a $188.9 million biorefinery. Its managing director is candid that the largest revenue line is not yet contracted. Australia has not met its international 90-day fuel reserve obligation since 2012. Around 90 per cent of the country’s liquid fuel is imported. Andy Whitmore, Managing […]
Forget Startups: Why Magnetic Alliance is Betting on “Boring” Mid-Market Turnarounds
While Australia’s venture capital scene spent years chasing unprofitable tech startups and speculative high-growth plays, Mark Lim was quietly taking a radically different path. The Managing Partner of Magnetic Alliance Capital sees the nation’s richest investment opportunities hiding in plain sight: inside thousands of unglamorous, profitable, but operationally sluggish mid-market businesses. Speaking on Wholesale Investor’s […]
The asset class where the market has no vote
Litigation funding returns are decided in a courtroom, not a cycle. Knightsbridge’s Head of Capital is careful to call that a different risk rather than a lower one, and his answer to it is spread, not concentration. Most alternative assets still answer to something. Property answers to rates. Private credit answers to defaults. Even the […]
See more exiting opportunities on CapitalHQ
Pictor
Powering diagnostics with protein signatures. Pictor is transforming health with its patented platform providing accessible, affordable, and scalable diagnostic solutions across the human and animal health verticals. PictArray can detect up to 10 diseases or biomarkers from one small serum, milk,…
HorizonTwo Capital Partners
HorizonTwo Capital Partners is a private equity firm that specialises in advanced manufacturing companies.
The Insides Company
First-in-class medtech for intestinal failure. Seeking remaining $1M of a $5M round, on a AUD$17.2M pre-money valuation.
DCARB
We are aiming to raise $CAD5M to fund the ongoing commercialisation of the D100 unit, including working capital to fund the expected growth in sales, and a field trial of the DArc unit. This follows a successful Series B round completed in mid-2023.
Grabba Technologies Pty Ltd
Advanced manufacturer of biometric identity authorisation products and electronics supplier to defence industry. We invite expressions of interest for up to $10.0M in growth capital.
Backed By Leading Investment Groups and Family Offices
